Načítá se...
Transplantation in Chronic Lymphocytic Leukemia (CLL): does it still matter in the era of novel targeted therapies?
Allogeneic stem cell transplantation (HSCT) offers the only potentially curative approach to the treatment of chronic lymphocytic leukemia (CLL). However, this is applicable only to a minority of CLL patients in view of the advanced age at presentation. Moreover, HSCT is associated with significant...
Uloženo v:
| Vydáno v: | Hematol Oncol Clin North Am |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4254558/ https://ncbi.nlm.nih.gov/pubmed/25459179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2014.08.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|